These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 25178484)

  • 61. GAPex-5 mediates ubiquitination, trafficking, and degradation of epidermal growth factor receptor.
    Su X; Kong C; Stahl PD
    J Biol Chem; 2007 Jul; 282(29):21278-84. PubMed ID: 17545148
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Loss of function Cbl-c mutations in solid tumors.
    Daniels SR; Liyasova M; Kales SC; Nau MM; Ryan PE; Green JE; Lipkowitz S
    PLoS One; 2019; 14(7):e0219143. PubMed ID: 31260484
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Myocardial KRAS(G12D) expression does not cause cardiomyopathy in mice.
    Dalin MG; Zou Z; Scharin-Täng M; Safari R; Karlsson C; Bergo MO
    Cardiovasc Res; 2014 Feb; 101(2):229-35. PubMed ID: 24259500
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Mutations in RIT1 cause Noonan syndrome - additional functional evidence and expanding the clinical phenotype.
    Koenighofer M; Hung CY; McCauley JL; Dallman J; Back EJ; Mihalek I; Gripp KW; Sol-Church K; Rusconi P; Zhang Z; Shi GX; Andres DA; Bodamer OA
    Clin Genet; 2016 Mar; 89(3):359-66. PubMed ID: 25959749
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Cbl and Cbl-b independently regulate EGFR through distinct receptor interaction modes.
    Pinilla-Macua I; Sorkin A
    Mol Biol Cell; 2023 Dec; 34(13):ar134. PubMed ID: 37903221
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Knockout of c-Cbl/Cbl-b slows c-Met trafficking resulting in enhanced signaling in corneal epithelial cells.
    Tarvestad-Laise K; Ceresa BP
    J Biol Chem; 2023 Oct; 299(10):105233. PubMed ID: 37690689
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Craniosynostosis and Noonan syndrome with KRAS mutations: Expanding the phenotype with a case report and review of the literature.
    Addissie YA; Kotecha U; Hart RA; Martinez AF; Kruszka P; Muenke M
    Am J Med Genet A; 2015 Nov; 167A(11):2657-63. PubMed ID: 26249544
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Ras/MAPK syndromes and childhood hemato-oncological diseases.
    Aoki Y; Matsubara Y
    Int J Hematol; 2013 Jan; 97(1):30-6. PubMed ID: 23250860
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Balancing Protein Stability and Activity in Cancer: A New Approach for Identifying Driver Mutations Affecting CBL Ubiquitin Ligase Activation.
    Li M; Kales SC; Ma K; Shoemaker BA; Crespo-Barreto J; Cangelosi AL; Lipkowitz S; Panchenko AR
    Cancer Res; 2016 Feb; 76(3):561-71. PubMed ID: 26676746
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Methods to Investigate EGFR Ubiquitination.
    Conte A; Sigismund S
    Methods Mol Biol; 2017; 1652():81-100. PubMed ID: 28791635
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Gain-of-function of mutated C-CBL tumour suppressor in myeloid neoplasms.
    Sanada M; Suzuki T; Shih LY; Otsu M; Kato M; Yamazaki S; Tamura A; Honda H; Sakata-Yanagimoto M; Kumano K; Oda H; Yamagata T; Takita J; Gotoh N; Nakazaki K; Kawamata N; Onodera M; Nobuyoshi M; Hayashi Y; Harada H; Kurokawa M; Chiba S; Mori H; Ozawa K; Omine M; Hirai H; Nakauchi H; Koeffler HP; Ogawa S
    Nature; 2009 Aug; 460(7257):904-8. PubMed ID: 19620960
    [TBL] [Abstract][Full Text] [Related]  

  • 72. MEK-ERK pathway modulation ameliorates disease phenotypes in a mouse model of Noonan syndrome associated with the Raf1(L613V) mutation.
    Wu X; Simpson J; Hong JH; Kim KH; Thavarajah NK; Backx PH; Neel BG; Araki T
    J Clin Invest; 2011 Mar; 121(3):1009-25. PubMed ID: 21339642
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Stable and EGF-Induced Temporal Interactome Profiling of CBL and CBLB Highlights Their Signaling Complex Diversity.
    Liu J; Yang L; He A; Ke M; Fu C; Gao W; Xu R; Tian R
    J Proteome Res; 2021 Jul; 20(7):3709-3719. PubMed ID: 34134489
    [TBL] [Abstract][Full Text] [Related]  

  • 74. [RIT1: a novel gene associated with Noonan syndrome].
    Arroyo-Carrera I; Solo de Zaldivar-Tristancho M; Martin-Fernandez R; Vera-Torres M; Gonzalez de Buitrago-Amigo JF; Botet-Rodriguez J
    Rev Neurol; 2016 Oct; 63(8):358-362. PubMed ID: 27699752
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Heterozygous germline mutations in A2ML1 are associated with a disorder clinically related to Noonan syndrome.
    Vissers LE; Bonetti M; Paardekooper Overman J; Nillesen WM; Frints SG; de Ligt J; Zampino G; Justino A; Machado JC; Schepens M; Brunner HG; Veltman JA; Scheffer H; Gros P; Costa JL; Tartaglia M; van der Burgt I; Yntema HG; den Hertog J
    Eur J Hum Genet; 2015 Mar; 23(3):317-24. PubMed ID: 24939586
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Deleterious c-Cbl Exon Skipping Contributes to Human Glioma.
    Seong MW; Ka SH; Park JH; Park JH; Yoo HM; Yang SW; Park JM; Park D; Lee ST; Seol JH; Chung CH
    Neoplasia; 2015 Jun; 17(6):518-24. PubMed ID: 26152360
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Noonan syndrome gain-of-function mutations in NRAS cause zebrafish gastrulation defects.
    Runtuwene V; van Eekelen M; Overvoorde J; Rehmann H; Yntema HG; Nillesen WM; van Haeringen A; van der Burgt I; Burgering B; den Hertog J
    Dis Model Mech; 2011 May; 4(3):393-9. PubMed ID: 21263000
    [TBL] [Abstract][Full Text] [Related]  

  • 78. De novo mutations in CBL causing early-onset paediatric moyamoya angiopathy.
    Guey S; Grangeon L; Brunelle F; Bergametti F; Amiel J; Lyonnet S; Delaforge A; Arnould M; Desnous B; Bellesme C; Hervé D; Schwitalla JC; Kraemer M; Tournier-Lasserve E; Kossorotoff M
    J Med Genet; 2017 Aug; 54(8):550-557. PubMed ID: 28343148
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Severe craniosynostosis with Noonan syndrome phenotype associated with SHOC2 mutation: clinical evidence of crosslink between FGFR and RAS signaling pathways.
    Takenouchi T; Sakamoto Y; Miwa T; Torii C; Kosaki R; Kishi K; Takahashi T; Kosaki K
    Am J Med Genet A; 2014 Nov; 164A(11):2869-72. PubMed ID: 25123707
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Mutations of c-Cbl in myeloid malignancies.
    Katzav S; Schmitz ML
    Oncotarget; 2015 May; 6(13):10689-96. PubMed ID: 26028666
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.